TG Therapeutics (TGTX) Alert: Johnson Fistel Investigates TG Therapeutics, Inc.; Investors Encouraged to Contact the Firm

Wednesday, September 26, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- Johnson Fistel, LLP, a shareholder rights law firm,

is investigating potential claims on behalf of investors of TG Therapeutics, Inc. (NASDAQ: TGTX) ("TG Therapeutics"). TG Therapeutics is a biopharmaceutical company that focuses on the acquisition, development, and commercialization of novel treatments
for B-cell malignancies and autoimmune diseases in the United States. [click here to join this action]

On September 26, 2018, TG Therapeutics closed down over 44% to close at $5.15. The price decline followed TG Therapeutics' announcement that it could not proceed with the interim analysis of UNITY-CLL as a result of the Data Safety Monitoring Board trials. These trials determined that the trial data was not mature enough to continue. 

If you are a shareholder who suffered a loss and are interested in learning more about your legal rights and remedies, please contact Jim Baker (jimb@johnsonfistel.com) by email or by phone at 619-814-4471. If you email, please include your phone number.

Additionally, you may [click here to join this action].There is no cost or obligation to you.

About Johnson Fistel, LLP: Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact: Johnson Fistel, LLPJim Baker, 619-814-4471jimb@johnsonfistel.com

[click here to join this action]

Cision View original content:http://www.prnewswire.com/news-releases/tg-therapeutics-tgtx-alert-johnson-fistel-investigates-tg-therapeutics-inc-investors-encouraged-to-contact-the-firm-300719000.html

SOURCE Johnson Fistel, LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store